26 September 2024 - BEAM AllianceNew York, From inside the UN buildings – Remko van LeeuwenJust a few hours ago the General Assembly of the UN has adopted a new declaration on fighting AMR. Regardless…read more >>
17 September 2024 - BEAM AllianceBEAM’s Reflection paper on General Pharmaceutical Legislation Revision: Taking Stock of the EU Parliament Position and Moving ForwardThe BEAM Alliance would like to reiterate its call for optimal PULL incentives designed to fit innovators’ needs based on…read more >>
24 October 2023 - BEAM AllianceBEAM Alliance shares its views on the ongoing revision of the General Pharmaceutical LegislationWe call on policymakers to stop postponing decisions and either propose a clear incentive package now or reintroduce the TEE…read more >>
05 September 2023 - BEAM AllianceBEAM Alliance is Launching a new Task Force to address Issues from the AMR Diagnostics SegmentThe new Task Force is gathering innovative SMEs operating in the AMR field and external experts.read more >>
16 June 2023 - BEAM AllianceBEAM’s reflection paper on the possible roles of DG HERAThe report represents an important step towards the implementation of a tangible solution to fix the AMR market. Although the…read more >>
23 May 2023 - BEAM AllianceBEAM’s statement on the EU Council Recommendation on AMRThe proposal examines AMR in a rather exhaustive way. It includes provisions on the need to strengthen national action plans,…read more >>
16 December 2024 - BasileaBasilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United StatesCeftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced generation cephalosporin antibiotic for intravenous administration, with rapid…read more >>
25 November 2024 - Centauri Therapeutics LtdCentauri Therapeutics awarded £1M grant under new PACE programme to advance immunotherapy platform in anti-infectives“We are excited to have support from PACE as we progress the development of our molecules in anti-infectives, and de-risk…read more >>
21 November 2024 - Debiopharm InternationalCARB-X Awards Additional Funding to Debiopharm for Continued Development of Early-Stage Antibiotic Targeting Drug-Resistant N. Gonorrhoeae InfectionsNow more than ever, new antibiotics are needed to avoid serious public health consequences caused by this infection.read more >>
13 November 2024 - AktheliaAkthelia Pharmaceuticals featured in Icelandic newspaper ViðskiptablaðiðThe article highlights the opportunity to advance our highly promising oral NCE therapeutic asset Gastrimod™️ (AKT-011) that we are exploring…read more >>
04 November 2024 - PHAXIAMPHAXIAM Therapeutics Receives FDA Clearance to Initiate Phase II GLORIA Study in the U.S.This FDA IND clearance is a major recognition of our therapeutic approach and of our whole platform. This is a…read more >>
30 October 2024 - Thioredoxin Systems ABTXN Systems Raises SEK 25 Million Series A to Advance First-in-Class AntibioticWith its novel mechanism of action on a new target, and extensive testing that has demonstrated its effectiveness against a…read more >>
21 January 2020REVIVE Webinar: Testing for the potential of emergence of resistanceThis presentation was also part of the 'Bootcamp: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process', jointly…read more >>
13 December 2019JPIAMR Hacking AMR 2019Finding digital solutions to fight Antimicrobial Resistance is our theme for this special international JPIAMR hackathon. The hackathon aim is…read more >>
05 December 2019Life Sciences Series #1The Ark Life Science Series #1 provides an excellent opportunity to exchange with representatives from all relevant sectors (pharmaceutical companies,…read more >>
26 November 2019REVIVE Webinar: Innovation in point-of-care diagnostics for sepsis and bloodstream infectionsIn this webinar our moderator Caroline Purslow (Nesta Challenges) will welcome three speakers. Till Bachmann (University of Edinburgh) will give…read more >>
13 November 2019Matchmaking Symposium ‘Emerging Antimicrobials and Diagnostics in AMR 2019’The event provides an excellent podium for emerging Antimicrobials and Diagnostics as well as an exciting program including orchestrated matchmakings,…read more >>
07 November 2019World Anti-Microbial Resistance CongressThe conference gathers global leaders in infectious diseases to meet, brainstorm and discuss the challenges and opportunities on seven topic…read more >>
07 November 2019REVIVE webinar: Converting Gram-positive-only compounds into broad-spectrum antibioticsThis webinar by Paul Hergenrother (Department of Chemistry and the Institute for Genomic Biology University of Illinois, US) will detail…read more >>
19 October 20194th International Course on Antibiotics and Resistance (ICARe)The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is…read more >>
03 October 2019REVIVE webinar: Natural products antibiotics: from traditional screening to novel discovery approachesIn this webinar, Olga Genilloud will discuss the role of natural products in current antibiotic discovery.read more >>
